Nasdaq, Inc. (NASDAQ: NDAQ) — The Exchange That Became a Software Company, Marked Down for a Panic Next Door

Independent fundamental research. As of 2026-06-27. All figures from primary filings, company disclosures, and public sources unless noted. Prices as of the 2026-06-26 close.

⚡ The Author’s Take

This block is the author’s own independent opinion and general information only — it is not investment advice. The analysis that follows takes no position and carries no price target; the single directional view in this piece lives in this block alone.

Verdict: HOLD / accumulate-on-weakness. A genuine quality compounder caught in someone else’s de-rate — own it, add in the low-to-mid $70s, don’t chase it back to par. Conviction: medium. Fair-value zone ≈ $92–108 (≈ 22–25× FY26 non-GAAP EPS of ~$4.00, or ~18–19× EV/EBITDA), versus the $78.56 close and the fresh $77.65 52-week low printed two days ago.

The thesis in one breath: over a decade, Nasdaq quietly stopped being a stock exchange and became a recurring-revenue data-and-software company that happens to own an exchange. Roughly 76% of net revenue is now Solutions — index licensing, listings, market data, IR/governance workflow, and a mission-critical financial-technology stack (Verafin anti-financial-crime, AxiomSL regulatory reporting, Calypso trading/risk). The legacy matching-engine business (Market Services) is down to ~23%. That mix earns a 44% GAAP operating margin (57% non-GAAP), a ~20% ROE, double-digit organic growth, and ~$2B of FCF. And the market knows it: NDAQ’s closest factor twins are Moody’s (0.97 similarity) and S&P Global (0.95) — it trades as an information-services compounder, not as an exchange.

So why is it at a 52-week low? Because on May 31, 2026 the CFTC approved Kalshi’s Bitcoin perpetual futures, and the entire exchange complex sold off on the fear that prediction-market “perps” could disintermediate regulated venues. The irony is that TD Cowen — cutting the group — named NDAQ the least exposed name (its derivatives revenue is small and commoditized), and Nasdaq is itself a prediction-market participant (SEC-cleared Outcome-Related Options on its MRX venue) and beneficiary (Nasdaq Private Market is Polymarket’s private-company data oracle). Layer on an AI/tech-sentiment rotation that pressures a franchise levered to equity-market levels, and a starting multiple that was admittedly rich (~26×), and you get a ~22% draw-down on a business whose Q1 2026 was the strongest start to a year in its history (+14% net revenue, +18% FinTech, record index AUM). Earnings grew into the falling multiple. Consensus price targets (~$109) now sit ~40% above the low.

What keeps this a HOLD and not a table-pound BUY: it still isn’t cheap in absolute terms (~20× forward non-GAAP, ~17× EBITDA, P/S at the 80th percentile of its own decade), the index/listings cyclicality the market is discounting is real (record AUM is a cyclical high, not a floor), and the governance is mediocre — comp contains no return-on-capital metric whatsoever despite >$13B of acquisitions, a combined Chair/CEO, and zero insider open-market buying as the stock fell. The reported 9.5% ROIC sits barely above cost of capital precisely because Nasdaq paid full price (~$10.5B) for Adenza; the franchise underneath is far better than that number, but per-share value creation now hinges on integration returns the pay plan does not measure.

Framing: abandoned-momentum quality compounder (Momentum factor −0.44), low-beta (~0.82), low idiosyncratic vol (19.6%) — a sentiment air-pocket in a good business, not a falling knife and not a value trap. Flips bullish if FinTech organic growth holds >15% and index AUM proves sticky through an equity drawdown (it re-rates back toward the data-compounder cohort). Flips bearish if a sustained market sell-off craters index AUM and the IPO pipeline while FinTech decelerates below 10%, or if prediction-market structures genuinely begin migrating regulated derivative volume off-exchange. Tag: “the exchange that became a software company, marked down for a panic next door.”

📈 Stock Price Action — Five-Year Event Map

Factual price history, not a recommendation. Price moves are FACT; attributed drivers are INTERPRETATION. All prices split-adjusted (Nasdaq executed a 3-for-1 split in August 2022); levels shown on the AZI adjusted-close series.

Over five years NDAQ ran from the high-$50s through a 2022 rate-shock trough (~$44.6, May 2022), a 2023 Adenza-deal air-pocket, a powerful 2024–2025 re-rating to an all-time high of $100.30 (Jan 16, 2026), and then a sharp ~22% give-back to a fresh 52-week low of $77.65 (June 25, 2026). It closed $78.56 on June 26, ~21.7% below the January high and ~15% below where it sat a month earlier. The round-trip is almost entirely a multiple story — net revenue and non-GAAP EPS rose in every one of those years.

Cycle narrative. (1) Like every richly-valued financial-data name, NDAQ de-rated hard in the 2022 rate shock even as earnings held. (2) The June 2023 Adenza announcement is the single clearest company-specific dislocation: a debt-and-equity-funded $10.5B deal that levered the balance sheet to ~4.7× and diluted holders ~15% — the stock fell double-digits on the print. (3)–(4) The 2024–2025 recovery was the market re-underwriting the transformation: deleveraging on schedule, FinTech compounding at high-teens, index AUM hitting records, the Thoma Bravo overhang cleared. (5) January 2026’s $100 high coincided with index AUM and the IPO calendar at cyclical peaks and a ~26× multiple. (6) Spring 2026 was choppy; the March 1 Investor Day raised targets but the stock had already priced perfection. (7) The June break is a sector event, not a Nasdaq event — the CFTC’s Kalshi-perps approval re-rated the whole exchange complex (CBOE −17% on the week, the worst hit), and an AI-driven tech sell-off pressured a franchise whose index and listings revenue tracks equity-market levels. NDAQ printed its 52-week low on June 25 even though its own Q1 had just delivered its best organic growth since 2021.

1. Executive Summary

Nasdaq, Inc. is no longer best understood as a stock exchange. After the 2021 Verafin acquisition and the transformational 2023 Adenza acquisition, it is a diversified financial-information-and-technology company organized into three divisions: Capital Access Platforms (data, listings, index licensing, IR/ESG/governance workflow — ~41% of net revenue, ~60% operating margin), Financial Technology (anti-financial-crime, regulatory reporting, and capital-markets trading/risk software — ~35% of net revenue, the growth engine at high-teens organic), and Market Services (the legacy cash-equities and options matching engines — ~23% of net revenue but high-margin). On a net-revenue basis (the only sensible topline, stripping out the ~$3B of transaction-rebate and clearing pass-throughs that inflate “gross” revenue to $8.3B), Nasdaq earned $5,249M in FY2025, up 12.9%, with a 44% GAAP / 57% non-GAAP operating margin, a ~20% ROE, and non-GAAP diluted EPS of $3.48 (+23%).

The business has three genuinely good moats and one mediocre one. Listings is a regulated duopoly with NYSE — high switching costs, brand, and a decade of net market-share gains (record $1.2T of listing transfers in 2025, including Walmart). Index licensing (the Nasdaq-100 / QQQ ecosystem) is a demand-captivity-plus-scale network with ~$882B of tracking ETP AUM — Greenwald’s strongest combination, though the fee is basis-point-priced and AUM-cyclical. Financial Technology sells mission-critical, deeply-embedded software (regulatory reporting and AML systems banks cannot easily rip out) with high retention and an attractive cross-sell motion. Market Services, by contrast, is a commoditized, regulated, rebate-driven matching business with little pricing power — the part of Nasdaq that least deserves a premium and, ironically, the part the June 2026 sell-off was about.

That sell-off is the setup. The stock fell from a $100.30 January high to a $77.65 June low — a 22% de-rate — on the CFTC’s May 31 approval of Kalshi Bitcoin perpetual futures (a prediction-markets “existential threat” scare that hit the whole exchange group, where NDAQ is the least exposed name), an AI/tech-sentiment rotation, and a starting multiple that was admittedly stretched. None of it was a fundamentals miss; Q1 2026 was the strongest start to a year in the company’s history.

The skeptic’s case is not about quality — it is about price and incentives. Even after the de-rate, NDAQ trades at ~20× forward non-GAAP earnings, ~17× EBITDA, and the 80th percentile of its own decade on price/sales — reasonable for the quality, not a bargain. The reported 9.5% ROIC barely clears the cost of capital because Nasdaq paid a full ~$10.5B for Adenza; the franchise economics underneath are excellent (tangible capital is negative), but value creation from here depends on integration returns that the compensation plan does not measure — there is no return-on-capital metric anywhere in the pay structure, the Chair and CEO roles are combined, and insiders bought zero shares on the way down. This is a high-quality, fairly-valued, well-run-but-not-perfectly-governed compounder that the market has handed back to investors at a more reasonable price for reasons that have little to do with Nasdaq.

2. Business Overview

Nasdaq operates three reportable segments. The critical first step in understanding the company is to discard the headline “Total revenues” figure ($8,262M in FY2025) and work from net revenue — “Revenues less transaction-based expenses” — of $5,249M. The ~$3,013M difference is transaction rebates paid to liquidity providers and brokerage/clearing/exchange fees that pass straight through Nasdaq’s income statement; they are economically not Nasdaq’s revenue and management, analysts, and this memo all use the net figure.

Capital Access Platforms (CAP) — FY2025 net revenue $2,137M (+9.9%), operating income $1,274M (59.6% margin). This is the crown-jewel franchise. It contains:

• Data & Listing Services (~$804M): proprietary market-data feeds and the listings business. Nasdaq listed 4,480 companies at year-end 2025 and hosted 281 IPOs — its 7th consecutive year as the #1 US exchange by IPO proceeds (>$24B raised). Listings revenue is annually recurring (companies pay listing fees) with very high retention.
• Index (~$827M, +17.1%): licensing of Nasdaq-branded indices (the Nasdaq-100 anchors QQQ, one of the world’s largest ETFs). Revenue is a basis-point fee on $882B of tracking ETP AUM (an all-time high), plus futures/options licensing. The segment took $99B of net inflows in 2025 and launched 122 new index products.
• Workflow & Insights (~$506M): IR intelligence, ESG/governance (Boardvantage), and analytics — largely subscription/SaaS.

Financial Technology (FinTech) — FY2025 net revenue $1,850M (+11.8% reported, +18% organic in Q1 2026), operating income $860M (46.5% margin). The growth engine, built by acquisition and now the strategic center of gravity:

• Financial Crime Management Technology (Verafin) (~$331M, +21.5%): cloud-native, consortium-data anti-money-laundering and fraud detection used by ~650 financial institutions.
• Regulatory Technology (AxiomSL) (~$428M, +16–21%): regulatory reporting and compliance software for banks.
• Capital Markets Technology (Calypso + trade management + market surveillance) (~$1,091M, +9.5–20%): front-to-back trading, treasury, and risk software, plus the SaaS surveillance platform.

Market Services — FY2025 net revenue $1,201M (+17.7%), operating income $764M (63.6% margin). The legacy exchange: cash-equity trading (~$515M net), equity-derivatives/options (~$463M net), FICC, and trade management. High-margin but commoditized — revenue is volume-and-rebate-driven, regulated, and shared with competing venues (NYSE, CBOE, MEMX, IEX). This is the cyclical, lower-quality piece, and it is shrinking as a share of the whole.

Revenue quality. Roughly 76% of net revenue is “Solutions” (CAP + FinTech) — recurring, subscription/SaaS, and data/index-licensing in character — versus ~23% transaction-based Market Services. Annualized Recurring Revenue (ARR) is ~$3.2B and growing ~12–13% organically; annualized SaaS revenue is ~38% of ARR and growing in the mid-teens. Verdict: a high-quality, predominantly recurring-revenue information-services and software business with a high-margin transactional exchange attached.

3. Industry Dynamics

Nasdaq sits at the intersection of two structurally attractive industries and one merely good one.

Exchanges & listings (good-to-excellent structure). Securities exchanges are natural oligopolies protected by regulation, network liquidity, and brand. US corporate listings are effectively a duopoly between Nasdaq and NYSE; switching venues is disruptive and rare, and the two compete on brand, services, and index inclusion rather than price. Listing fees are recurring and sticky. The structural risks are long-tail: new SEC-approved venues — 24X National Exchange (live October 2025) and the Texas Stock Exchange (SEC-approved September 2025, targeting production trading July 2026 and IPO capability late 2026) — plus IEX and MEMX in trading. These are credible threats to trading market share and market-data economics over time but unproven; near-term, Nasdaq’s listings franchise is gaining share (record $1.2T of transfers to Nasdaq in 2025, including the largest exchange transfer in history, Walmart, and the June 2026 SpaceX IPO).

Index & financial data (excellent structure). This is the business that earns Nasdaq its “compounder” multiple. Index licensing is a demand-captivity-plus-scale machine: once an ETF (QQQ) or a derivatives complex is built on an index, the entire ecosystem of products, liquidity, and benchmarks is locked to that index, and incremental AUM costs almost nothing to serve. The comparables are S&P Global (>$10T indexed to S&P/Dow), MSCI (>$16.5T linked to its indices), and FTSE Russell. The structural caveat — flagged explicitly by MSCI — is basis-point fee compression: as AUM migrates to ultra-low-cost ETFs, the licensing fee per dollar of AUM erodes, so dollar revenue growth lags AUM growth, and the whole pool is levered to equity-market levels (a sustained drawdown shrinks AUM and the fee base).

Financial technology / RegTech / AML (good and growing). The anti-financial-crime software market is ~$25B growing to ~$40B by 2030 (~10% CAGR), with regulatory tailwinds (rising compliance burden). It is competitive — NICE Actimize (enterprise incumbent), Feedzai, Featurespace (bought by Visa for ~$1.1B), SAS, Oracle, FICO — but switching costs are high once a bank embeds an AML or regulatory-reporting system into its risk workflow. Nasdaq’s edge is its cloud-native, consortium-data model (Verafin) and the unified risk-plus-crime data layer it is building across Verafin and Adenza.

Regulatory landscape (revenue-relevant, mostly headwinds at the margin). Two SEC actions touch Market Services: the Section 31 fee was cut to $0.00/million in May 2025 (pure pass-through, optically reduces gross revenue) and the 2024 tick-size/access-fee rule (access-fee cap cut from 30 mils to 10 mils, compliance November 2025, upheld on appeal October 2025) compresses the maker-taker rebate economics in the lowest-value segment. The June 2026 CFTC approval of Kalshi perpetual futures is the prediction-markets regulatory question driving the sector sentiment. Verdict: structurally attractive on balance — two excellent businesses (index/data, listings) and a good one (FinTech), with the cyclical, regulation-pressured exchange piece a shrinking minority.

4. Competitive Position

Nasdaq’s moat is real but heterogeneous — it must be assessed segment by segment, because the consolidated 9.5% ROIC (goodwill-bloated) hides three very different competitive realities.

Listings — a regulated duopoly moat (Greenwald: customer captivity + brand + scale). Once a company lists on Nasdaq, it almost never leaves; the brand (the MarketSite, the bell, the Nasdaq-100 association) and the disruption of switching create captivity. The financial proof that this is a moat: listings revenue is annually recurring at very high retention, and Nasdaq has gained share for over a decade — the record $1.2T of transfers to Nasdaq in 2025 (net inflow of large-caps from NYSE) is the moat surfacing in market-share data. The threat is structural and slow (TXSE/24X), not cyclical.

Index — the strongest moat (Greenwald: economies of scale + demand captivity / network effects). The Nasdaq-100 is a self-reinforcing standard: QQQ’s liquidity attracts more assets, which deepens the futures/options ecosystem, which makes the index more useful as a benchmark, which attracts more product. A competitor cannot simply launch a “better Nasdaq-100”; the network is the product. Incremental AUM is almost pure margin. The financial proof is the 59.6% CAP operating margin and the +17% index-revenue growth on +32% average AUM. The vulnerability is price, not displacement: basis-point fees compress over time, and the AUM base is cyclical.

Financial Technology — switching-cost moat, contestable at the edges. Regulatory-reporting (AxiomSL) and AML (Verafin) systems are mission-critical and deeply embedded in a bank’s risk and compliance plumbing; ripping one out mid-cycle is expensive and risky, which is why retention is high and the cross-sell motion works. But this is a competitive market with well-capitalized incumbents (NICE Actimize, SAS, Oracle, Visa/Featurespace), so the moat is “high switching costs once embedded” rather than “no alternative” — durable but requiring continuous product investment to defend.

Market Services — the weakest moat (near-commodity). Trade execution is regulated, fungible, and price-competitive across a dozen venues; Nasdaq’s matching engine is excellent but its pricing power is constrained by Reg NMS, the rebate model, and the access-fee cap. The moat here is thin — speed, technology, and incumbency, not captivity. Verdict: a durable, multi-source competitive advantage concentrated in index and listings, supported by switching costs in FinTech, with a commoditized trading business that the market over-weights when it panics about exchange disruption.

5. Growth History and Forward Opportunities

History. Net revenue compounded from $3,895M (FY2023) to $4,649M (FY2024, +19.4%, Adenza added for a full year) to $5,249M (FY2025, +12.9%). Stripping acquisition effects, organic net-revenue growth has run low-double-digits, and Q1 2026 delivered the highest Q1 organic growth since 2021 (+13% organic net revenue) — front-loaded by FinTech’s best-ever quarterly revenue growth (+18%). This is high-quality growth: it is recurring (ARR +12–13% organic), broad-based (all three divisions grew double-digits in Q1 2026), and margin-accretive (Q1 2026 non-GAAP operating margin expanded ~2 points to 57%).

Forward opportunities. Management’s March 2026 Investor Day medium-term framework: CAP organic 6–10%, FinTech organic 10–14%, Solutions blended 9–12% (raised from 8–11%). The specific drivers:

• FinTech cross-sell (“One Nasdaq”). The flagship thesis: sell Verafin + AxiomSL + Calypso into the same bank relationships and build a unified risk-and-financial-crime data layer. Net-revenue-retention and cross-sell are the engine; the +18% FinTech organic growth is the early proof.
• Index AUM and new products. 122 new index products in 2025, growing international and insurance-annuity demand, and the SpaceX-driven Nasdaq-100 fast-track inclusion (estimated ~$4.3B passive inflow). Growth here is part secular (passive adoption) and part cyclical (equity levels).
• Market modernization & optionality. Options migration to the Fusion platform (7 of 8 markets live), a planned 23/5 “always-on” trading debut (targeted December 2026, pending approval), Outcome-Related Options (the regulated prediction-market product), and a management-sized $3–6B tokenization opportunity. These are call options, not base-case revenue.
• AI productivity. A GenAI program targeting $100M of run-rate efficiencies by end-2027 and Verafin’s agentic-AI workforce (adopted by 500–650 institutions) — both a margin lever and a product differentiator.

Verdict: high-quality, durable, mostly-organic growth in the low-double-digits, concentrated in the highest-margin segments — but with a cyclical kicker (index AUM, listings) that flatters the trailing numbers and would reverse in an equity-market drawdown.

6. Financial Quality

Margins and returns. FY2025 net revenue $5,249M produced GAAP operating income of $2,331M (44.4% margin, up from 38.7% in FY2024 as Adenza integration costs normalized) and non-GAAP operating margin of ~56–57%. EBITDA margin is ~37% on gross revenue but ~60% on net revenue. ROE is ~19.9%; ROA 5.8%. ROIC is 9.5% — and this number requires careful interpretation. It is depressed by the $20.9B of goodwill and intangibles ($14.4B goodwill + $6.5B intangibles) sitting on the balance sheet from Adenza ($5.9B goodwill + $5.1B intangibles) and Verafin. Tangible common equity is negative (~−$8.6B). In other words, the operating businesses earn extraordinary returns on the modest tangible capital they actually employ; the 9.5% consolidated ROIC reflects the price Nasdaq paid for acquired growth, not the economics of the franchises. Both readings are true and both matter: the franchise is excellent, and the capital deployed to assemble it earns only a market-average return.

Cash generation. FY2025 operating cash flow was $2,255M against just $266M of capex (this is a capital-light business), for ~$1,989M of free cash flow — roughly 1.1× net income, clean conversion. FCF comfortably covered $601M of dividends and $616M of buybacks with room to pay down debt.

Balance sheet — read carefully. The balance sheet looks alarming at a glance (negative TCE, $8.0B current liabilities) but most of the scale is clearing-member collateral, not Nasdaq money: ~$5.8B of “default funds and margin deposits” appears on both sides of the balance sheet and is explicitly held on behalf of clearing members. Real corporate liquidity is only ~$604M of cash plus ~$28M of investments — do not net the ~$3.1B of restricted/default-fund cash against debt. Total debt is $9,004M (down from $9,480M), weighted-average rate ~3.7%, investment-grade rated, with a well-laddered maturity profile (no tower of near-term maturities). Net debt is ~$8.4B, and gross leverage is 2.8× — within management’s post-Adenza target range, down from ~4.7× at deal close. The deleveraging story is essentially complete.

Quality-of-earnings flags. (1) GAAP-to-non-GAAP wedge: non-GAAP EPS ($3.48) exceeds GAAP ($3.09) by ~$0.39, driven by ~$487M of acquired-intangible amortization (~$0.84/share, a real economic cost of the M&A strategy that non-GAAP excludes — treat non-GAAP as the cleaner run-rate but remember the amortization reflects capital actually spent). (2) FY2025 GAAP EPS was flattered by a low 16.7% tax rate (vs 23.1% in FY2024) and an $86M divestiture gain — normalize both before extrapolating GAAP. (3) SBC is modest at $165M (~3% of net revenue). Verdict: economics clearly improve with scale (margins expanding, capital-light, clean cash conversion, ~20% ROE), but the acquisition-heavy build leaves consolidated ROIC at only ~cost-of-capital and a goodwill-laden balance sheet — the quality is in the franchises, the mediocrity is in the price paid to assemble them.

7. Capital Allocation

Capital allocation is a growth-and-deleverage story with one structural blind spot.

M&A — the defining decisions. Nasdaq spent ~$13B+ over four years building FinTech: Verafin (2021, ~$2.75B) and Adenza (November 2023, ~$10.5B — $5.8B cash + $4.2B/85.6M shares to Thoma Bravo). Adenza is the bet that defines the equity: it added AxiomSL and Calypso, levered the balance sheet to ~4.7×, diluted shareholders ~15%, and put $20.9B of goodwill/intangibles on the books. The strategic logic (recurring-revenue software, cross-sell into bank relationships) is coherent and the early organic growth (+18% FinTech) is encouraging — but the price was full, and the ~9.5% consolidated ROIC is the arithmetic consequence. There has been no goodwill impairment through 2025, which is the right test passing so far. Separately, Nasdaq divested its non-core Nordic power/commodities business in 2025 for an $86M gain — sensible pruning.

Deleveraging — executed well. Net debt fell $10.0B → $8.9B → $8.4B (FY2023–25); gross leverage is back to 2.8×, within target. Management repaid $826M of debt in FY2025 ($812M in FY2024). The post-Adenza balance-sheet repair is done, which is what freed up capital return.

Shareholder return — resumed and compounding. Buybacks were deliberately cut to prioritize deleveraging ($269M FY2023, $145M FY2024) and then resumed at $616M in FY2025 — and accelerated to $548M in Q1 2026 alone (management explicitly “took advantage of market volatility”), against a $3B authorization. The dividend has compounded ~10%/year ($0.65 → $1.05 per share FY2020–25, raised to $0.31/quarter in 2026), at a comfortable ~34% payout. A meaningful technical positive: the ~15% Thoma Bravo overhang from the Adenza deal has been fully cleared (below 5% by May 2025), partly via a company buyback of TB shares — a large motivated seller is gone.

The blind spot — incentives. Here the skeptic’s verdict is unambiguous. Across the entire compensation plan there is no return-on-capital metric of any kind — the annual bonus pays on operating income (50%), net revenue (20%), ARR (5%), and strategic initiatives (25%); the long-term plan is 80% relative-TSR PSUs. For a company that has deployed >$13B of acquisition capital and levered its balance sheet to do so, paying management to grow revenue and operating income — but never to earn a return on the capital deployed — is a genuine governance gap. It is compounded by a combined Chair/CEO and zero insider open-market purchases across 2024–2026 (all activity is grants, vesting, and sales; the single code-P filing in the window is a strategic 10% holder, not an officer). Say-on-pay passed at 96%, and governance hygiene is otherwise fine (clawback, ownership guidelines, no-hedge/no-pledge). Verdict: capable, coherent capital allocation — good deleveraging, sensible pruning, resumed compounding returns, a cleared overhang — undercut by an incentive structure that does not hold management accountable for the returns on its largest capital decisions.

8. Changes and Headwinds — Last Two Years

• The Adenza integration (2023→present) is the dominant change: a new ~$1.85B FinTech division, ~$5.6B of new debt now substantially worked down, ~15% dilution, and a new strategic identity (“One Nasdaq”). Tracking well so far (+18% FinTech organic, no impairment), but it is the central execution risk.
• Leadership: Adena Friedman became Chair (Jan 2023) on top of CEO; Sarah Youngwood joined as CFO (December 2023); Tal Cohen elevated to President. Leadership is stable.
• The Thoma Bravo overhang cleared (2024–2025) — a large seller removed.
• 2025 divestiture of the Nordic power/commodities business ($86M gain).
• Regulatory: Section 31 fees cut to zero (May 2025, pass-through); the 2024 tick-size/access-fee rule (compliance Nov 2025, upheld Oct 2025) modestly compresses Market Services rebate economics; the May 2026 CFTC Kalshi-perps approval is the prediction-markets question now overhanging the sector.
• Prediction-markets positioning (2026): Nasdaq turned a threat into a product/partnership — SEC-cleared Outcome-Related Options on MRX and Nasdaq Private Market as Polymarket’s private-company data oracle.
• Headwinds: an AI/tech-sentiment rotation and equity-market drawdown that pressures the AUM- and listings-cyclical parts of the model; basis-point index-fee compression; and a still-full valuation. Verdict: the operational changes strengthen the thesis (FinTech scaling, balance sheet repaired, overhang gone); the headwinds are primarily market-sentiment and cyclical, not company-specific deterioration.

9. Risk Analysis (Risk Matrix)

The dominant risks are cyclical (equity-market levels driving index AUM and listings) and valuation/incentive, not solvency or franchise erosion. The prediction-markets risk that drove the June de-rate is, on the evidence, the least well-matched to Nasdaq’s actual exposure.

10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation. This section frames the expectations embedded in the current price and the scenarios around them.

At the $78.56 close, ~570M shares give a market cap of ~$45B; adding ~$8.4B of net (corporate) debt yields an enterprise value of ~$53.5B. Against that:

• EV / net revenue (~$5.4B TTM): ~10×
• EV / EBITDA (TTM ~$3.17B): ~17×
• P/E: ~23.7× trailing GAAP ($3.32), ~20× forward non-GAAP (FY2026 ~$4.00), ~22.6× trailing non-GAAP ($3.48)
• FCF yield: ~$2.0B FCF / ~$45B cap ≈ ~4.4%
• Dividend yield: ~1.6% ($1.24 annualized)

Own-history context (AZI valuation percentiles). This is the tell that the de-rate is real but partial: NDAQ’s composite valuation sits at the 55.8th percentile of its own multi-year range — middling, not cheap. The P/E percentile is the 32.7th (genuinely below its own median, because earnings grew while the multiple fell), but the P/S percentile is the 80th (still elevated, because net revenue compounded so strongly that price/sales never got cheap). In plain terms: NDAQ has de-rated meaningfully on earnings multiples but remains richly valued on sales — it is reasonably priced, not a bargain.

Cross-sectional context. NDAQ’s factor twins are the data-compounder cohort: Moody’s (~30–35× forward) and S&P Global (~30× forward) trade well above NDAQ’s ~20× forward non-GAAP, while the exchange cohort — ICE (~20×), CME (~22×), CBOE (~22×) — trades roughly in line. NDAQ is a hybrid, and at ~20× forward it is priced at the low end of the data-compounder group and in line with exchanges — defensible given the mix, neither cheap versus the compounders nor expensive versus the exchanges.

Embedded-expectations / reverse-DCF. To justify a ~$53.5B EV on ~$2.0B of FCF at a ~9% discount rate requires roughly 7–8% perpetual FCF growth. Given ~10–12% organic net-revenue growth in the highest-margin segments, expanding margins, and an AI-driven efficiency program, that hurdle is achievable in the base case — the market is not underwriting heroics. The de-rate from January removed the premium that was demanding (~26× P/E embedded ~9–10% perpetual growth on a cyclically-elevated AUM base). What the market is pricing correctly: that index AUM and listings are at cyclical highs and the prior multiple left no margin of safety. What it may be pricing incorrectly: the durability of FinTech’s high-teens organic growth and the fact that NDAQ is the least perps-exposed name in the group it was sold with.

Scenarios (illustrative, no price target):

• Bear (equity drawdown shrinks AUM/listings, FinTech decelerates below 10%, multiple compresses to ~16× EBITDA / ~16× non-GAAP): EPS power stalls near $3.6–3.8 and the stock re-rates toward the high-$50s–low-$60s.
• Base (Solutions compounds 9–12%, FinTech high-teens, margins expand, multiple holds ~17–18× EBITDA / ~20× non-GAAP on FY2026 ~$4.00): mid-$80s–mid-$90s.
• Bull (FinTech sustains >15%, AUM proves sticky, the market re-rates NDAQ back toward its MCO/SPGI data-compounder twins at ~24–25× non-GAAP): $100–110+.

The asymmetry from $78 is roughly balanced-to-favorable — limited absolute cheapness, but a quality franchise that has handed back its premium for sentiment reasons.

11. Variant Perception

Consensus. Sell-side is broadly constructive (median PT ~$109, ~40% above the recent low; mostly Buy ratings) — the Street views the de-rate as a sentiment air-pocket in a quality compounder and the estimates have not come down. The bear minority argues the multiple was simply too high for a business with a large cyclical (AUM/listings) component and that the perps/disruption risk is being underestimated.

The strongest bull case. Nasdaq is a misclassified information-services compounder. ~76% of net revenue is recurring data/index/software; FinTech is compounding at high-teens organically with a long cross-sell runway; index and listings are durable, share-gaining franchises; the balance sheet is repaired; the Thoma Bravo overhang is gone; buybacks have resumed and accelerated into the weakness; and the market just handed the stock back at ~20× forward — the low end of its data-compounder peers — for a fear (prediction-market perps) that hits it least. If FinTech holds and the market re-rates NDAQ toward MCO/SPGI, the upside is substantial.

The strongest bear case. NDAQ is a financial exchange wearing a software-company costume, priced for a compounding it cannot fully control. A large slice of its highest-margin revenue (index AUM, listings) is levered to equity-market levels that are at cyclical highs; basis-point index fees erode structurally; the 9.5% ROIC says the company paid full price for its growth and the comp plan does not even measure the return; insiders aren’t buying; and at the 80th percentile of its own price/sales history it offers little margin of safety if the cycle turns and FinTech growth normalizes.

The 3–5 assumptions that matter most (and what would falsify each):

1. FinTech organic growth is durable (high-teens → low-teens). Falsified if organic FinTech growth decelerates below 10% for two+ quarters (cross-sell exhausting, integration stalling).
2. Index AUM is structurally growing, not just cyclically high. Falsified if a sustained equity drawdown shrinks ETP AUM 20%+ and index revenue declines despite “new product” launches.
3. The prediction-markets threat is overstated for NDAQ specifically. Falsified if regulated perpetual/event contracts begin migrating meaningful options/derivatives volume off Nasdaq’s venues.
4. Capital allocation stays disciplined (no value-dilutive mega-deal). Falsified if management deploys the resumed firepower into another full-priced acquisition without a return-on-capital hurdle.
5. The de-rate is sentiment, not estimate-cut. Falsified if consensus FY2026–27 estimates start falling (so far they have not).

Factor-positioning read. The tape corroborates “abandoned-momentum quality,” not “broken business”: Momentum loading −0.44 (out of favor), Value −0.30 (still priced as growth, not value), LowVol +0.26, beta ~0.82, idiosyncratic vol ~19.6%, and a y1 return of −11% with negative 3-/6-month momentum. NDAQ’s factor twins are Moody’s (0.97) and S&P Global (0.95) — the market models it as an information-services compounder that has simply fallen out of favor, which is exactly the profile of a sentiment-driven entry rather than a falling knife.

12. Fact vs. Interpretation Table

13. Open Questions

1. What is the true organic FinTech growth rate ex-cross-sell pull-forward? Q1 2026’s +18% is strong but management flagged a ~4% one-timer; the durable run-rate matters enormously for the multiple.
2. How sticky is index AUM in a real drawdown? The model has never been tested with a 30%+ equity decline at this AUM scale; how much of the $882B is “core” passive vs. flighty.
3. What is the basis-point fee trajectory on index revenue? Is dollar revenue growth meaningfully lagging AUM growth (MSCI’s experience), and by how much?
4. Will management impose a return-on-capital discipline before the next deal? With a repaired balance sheet and $3B of buyback authorization, what is the M&A appetite, and at what return hurdle?
5. How real is the TXSE/24X listings threat over 3–5 years? Could a credible third venue erode listings/market-data economics, or will it remain a duopoly?
6. What is normalized GAAP EPS once the FY2025 tax-rate benefit (16.7%) and divestiture gain are removed and amortization is held flat?

14. What Must Be True

For the bull case (own it / re-rates to $100+):

• FinTech organic growth holds in the mid-teens and Solutions compounds 9–12% for multiple years, proving the “information-services compounder” classification.
• Index AUM and listings prove durable (not merely cyclically high), so the highest-margin pool keeps growing through a normal market cycle.
• Capital allocation stays disciplined — buybacks at depressed prices, no value-dilutive mega-deal — and the market re-rates NDAQ toward its MCO/SPGI twins.
• Falsification test: two consecutive quarters of sub-10% FinTech organic growth, OR an index-revenue decline despite flat-to-up product counts, OR a new full-priced acquisition announced without a stated return hurdle — any one breaks the bull case.

For the bear case (avoid / re-rates to high-$50s–low-$60s):

• A sustained equity-market drawdown shrinks ETP AUM and the IPO pipeline, exposing how much of NDAQ’s “quality compounding” was cyclical AUM/listings tailwind.
• FinTech growth normalizes below 10% as cross-sell matures and competition (NICE Actimize, SAS, Visa/Featurespace) intensifies.
• The ~20× forward / 80th-percentile-on-sales multiple compresses as the market re-treats NDAQ as a part-cyclical exchange rather than a pure compounder.
• Falsification test: FinTech organic growth re-accelerates above 15% while index AUM grows through an equity drawdown, OR consensus estimates rise rather than fall — either dissolves the bear case.

15. Source Appendix

See the Source Appendix (Appendix B) for the full, dated, primary-source citation list. Principal sources: Nasdaq, Inc. FY2025 Form 10-K (filed 2026-02-12) and FY2023–24 10-Ks; Q1 2026 Form 10-Q (filed 2026-04-24); Q1 2026 earnings release and call transcript (2026-04-23); FY2026 DEF 14A proxy (2026-04-24); Thoma Bravo SC 13D/A filings and 424B7 secondaries; Nasdaq Q4/FY2025 release (2026-01-29) and March 2026 Investor Day materials; ROIC.ai fundamental data; AZI valuation percentiles and price history; Factorstoday factor model; and contemporaneous reporting on the May–June 2026 prediction-markets/CFTC developments (CNBC, Reuters, TD Cowen/RBC notes).

APPENDIX A — Standard Diligence Questionnaire

Nasdaq, Inc. (NASDAQ: NDAQ) — as of 2026-06-27

Supplemental to the memo. Fact / Interpretation / Assumption labels applied where it matters.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debates: (1) Is Nasdaq a “compounder” deserving a Moody’s/S&P-style multiple, or a part-cyclical exchange whose index/listings revenue is levered to equity-market levels? (2) Did it overpay for Adenza (~$10.5B, ~9.5% consolidated ROIC)? (3) How durable is FinTech’s high-teens organic growth and how big is the cross-sell runway? (4) How much of index revenue growth is secular passive-adoption vs. cyclical AUM? (5) What is the basis-point fee erosion on index licensing? (6) Does the prediction-markets/perps shift threaten or benefit Nasdaq? (7) Why no return-on-capital metric in comp despite >$13B of M&A?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: Mixed but tilted to a high. FinTech (recurring software) is structurally growing and not particularly cyclical. But index revenue is a basis-point fee on a record $882B of ETP AUM, and listings/IPO revenue tracks equity-market levels — both are at or near cyclical highs. A sustained equity drawdown would compress the highest-margin pool. Market Services volumes are also elevated. So consolidated earnings are flattered by cyclical tailwinds.

Driven by the external environment or internal actions? Both. Internal: the Adenza/Verafin build, “One Nasdaq” cross-sell, margin expansion, deleveraging. External: elevated equity markets (AUM/listings/volumes), the IPO cycle.

How stable are revenues? Fact: ~76% of net revenue is recurring “Solutions” (data, index, listings, SaaS) with high retention and ~$3.2B of ARR growing ~12–13% organically. The ~23% Market Services piece is transactional and more volatile. Overall revenue is far more stable than a pure exchange.

Outlook for products/services? Solutions organic 9–12% medium-term (CAP 6–10%, FinTech 10–14%) per the March 2026 Investor Day; AI-efficiency program ($100M run-rate by end-2027); optionality in 23/5 trading, tokenization, and prediction-market products.

How big will this market be? Index/data and RegTech/AML are secularly growing (AML ~$25B→$40B by 2030, ~10% CAGR; passive AUM rising). Listings is a mature duopoly; trading is mature/commoditized. International expansion is a real runway.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Interpretation: Stable-to-slightly-more in trading (new venues TXSE/24X, but unproven) and FinTech (well-funded incumbents). Listings and index remain protected oligopoly/network franchises.

How profitable is the business (ROIC, ROE)? Fact: ROE ~19.9%; GAAP operating margin 44.4% (57% non-GAAP); EBITDA margin ~60% of net revenue. ROIC ~9.5% — depressed by $20.9B of goodwill/intangibles from acquisitions; underlying tangible-capital returns are far higher (TCE is negative). Interpretation: the franchises are excellent; the consolidated return reflects the price paid for M&A.

How profitable is the industry — competitors, barriers? High. Exchanges and index/data are among the most profitable financial-services niches (regulation, network effects, scale). Barriers to entry are very high in listings/index; moderate-to-high in FinTech (switching costs); lower in trade execution.

Can the business be easily understood? Moderately. The three-segment structure is clear, but the gross-vs-net revenue distinction, the clearing-collateral balance-sheet gross-up, and the GAAP/non-GAAP amortization wedge all require care.

Undermined by foreign low-cost labor? No — it is a regulated, network/software business, not labor-cost-exposed.

Do brands matter? Yes — the Nasdaq brand (MarketSite, Nasdaq-100, the bell) is a genuine listings asset and the index brand anchors QQQ.

Nature of competition / switching costs? Listings: very high switching costs (captivity). Index: network lock-in. FinTech: high embedded switching costs once a bank installs an AML/regulatory system. Market Services: low — venue-fungible execution.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Interpretation: The Nasdaq brand, the index franchise/network, and listings relationships are worth far more than carried; conversely, much of the $14.4B goodwill reflects acquisition premia.

Off-balance-sheet liabilities? Operating leases (modest); the ~$5.8B “default funds and margin deposits” are on-balance-sheet but are clearing-member collateral, equal-and-offsetting on both sides — not Nasdaq’s money. No unusual off-balance-sheet exposures identified.

How conservative is the accounting? Reasonable. Flags: non-GAAP excludes ~$487M/yr of real acquired-intangible amortization; FY2025 GAAP was flattered by a 16.7% tax rate and an $86M divestiture gain. No goodwill impairment through 2025.

How CapEx-hungry? Capital-light: FY2025 capex ~$266M on $5.25B net revenue (~5%); FCF conversion ~1.1× net income.

Capital Allocation & Management

How much FCF, and how is it used? ~$2.0B FY2025 FCF → dividends ($601M), buybacks ($616M, accelerated to $548M in Q1 2026 alone), and debt paydown ($826M). Philosophy: deleverage post-Adenza (done, 2.8× gross), then compound dividend + opportunistic buyback.

Significant acquisitions recently? Verafin (2021, $2.75B) and Adenza (2023, ~$10.5B) — the defining capital decision. 2025 divestiture of Nordic power/commodities ($86M gain).

Buying back shares? Yes — resumed FY2025 ($616M) after a deleveraging pause; $3B authorization; share count edging down post-Adenza dilution.

Issuing shares to insiders? SBC modest (~$165M, ~3% of net revenue). The big issuance was the 85.6M shares to Thoma Bravo for Adenza (~15% dilution, now fully resold to the market).

Compensation policy of directors/management? Fact: CEO Friedman FY2025 total $25.0M, 93% at-risk; bonus on operating income/net revenue/ARR/strategic initiatives; LTI 80% relative-TSR PSUs. No return-on-capital metric anywhere. Say-on-pay 96%. Interpretation: a genuine incentive gap for a serial acquirer.

Motivations of management? Revenue/operating-income growth, relative TSR, and the strategic transformation — not capital efficiency. Combined Chair/CEO; zero insider open-market buying 2024–2026.

Valuation & Market Data

ADR / MLP / K-1? No — a US C-corp common stock; standard 1099 dividend treatment.

Dividend policy? ~10%/yr-growing dividend, $0.31/quarter ($1.24 annualized, ~1.6% yield), ~34% payout.

How profitable? Very — see above (~20% ROE, 44% GAAP operating margin).

Net income diverging from cash from operations? Fact: FY2025 OCF $2,255M vs net income $1,788M (OCF/NI ~1.26×) — cash generation runs ahead of GAAP net income (amortization is a large non-cash charge), a positive quality signal.

Risks & Downside

What would cause the stock to decline? A sustained equity-market drawdown (shrinking index AUM/listings/volumes); FinTech growth decelerating below 10%; multiple compression from a still-full ~20× forward / 80th-percentile-on-sales starting point; a value-dilutive acquisition; or a genuine prediction-market disintermediation of regulated derivatives.

Risk of catastrophic loss? Low. A core financial-infrastructure operator with diversified, recurring revenue, investment-grade credit, and ~$2B FCF. A catastrophic outcome would require a severe cyber/operational event or a regulatory upheaval to data/listing economics — low-probability.

Chance of total loss? Negligible — durable franchises, strong cash generation, manageable leverage (2.8×).

Recent News & Events

Has the business environment changed recently? Fact: (1) The May 31, 2026 CFTC approval of Kalshi BTC perpetual futures triggered a sector-wide de-rate; (2) an AI/tech-sentiment rotation pressured equity-levels-levered franchises; (3) the stock hit a fresh 52-week low ($77.65, June 25). None reflects a Nasdaq fundamentals miss — Q1 2026 was its strongest start to a year on record.

Significant acquisitions / divestitures? Adenza/Verafin (prior); 2025 Nordic power/commodities divestiture.

Change in accounting policies? None material identified.

Recent operational changes? “One Nasdaq” three-division reorg; options migration to Fusion; planned 23/5 trading (Dec 2026, pending approval); SEC-cleared Outcome-Related Options; Nasdaq Private Market as Polymarket’s data oracle; GenAI efficiency program; CFO Youngwood (Dec 2023) and President Cohen elevations.

APPENDIX B — Source Appendix

Nasdaq, Inc. (NASDAQ: NDAQ) — research as of 2026-06-27

Primary sources first. Dates are filing/publication or access dates. Aggregator data (ROIC.ai, AZI, Factorstoday) is third-party and reconciled to filings; the filing wins on any material discrepancy.

Primary — SEC filings (EDGAR, CIK 0001120193)

1. Form 10-K, FY2025 (period 2025-12-31; filed 2026-02-12) — ndaq-20251231.htm. Segment net revenue/operating income (Note 19); non-GAAP reconciliation; ARR/SaaS by sub-segment; ETP AUM rollforward ($882B, $99B net inflows); debt note ($9,004M, ~3.7% WAR, maturity ladder); default-funds/margin-deposits disclosure; listings count (4,480) and IPOs (281); no goodwill impairment.
2. Form 10-K, FY2024 (filed 2025-02-21) and FY2023 (filed 2024-02-21) — ndaq-20241231.htm, ndaq-20221231.htm (and FY2023). Adenza purchase-price allocation ($9,984M consideration; $5,814M cash + 85.6M shares; $5,933M goodwill + $5,050M intangibles); transaction-based-expense detail; multi-year net revenue.
3. Form 10-Q, Q1 2026 (period 2026-03-31; filed 2026-04-24) — net revenue $1,407M; segment growth; gross leverage 2.8×.
4. DEF 14A proxy, 2026 (filed 2026-04-24) — ndaq-20260424.htm. Executive compensation metrics and weightings (operating income 50% / net revenue 20% / ARR 5% / strategic 25%; LTI 80% relative-TSR PSUs); no return-on-capital metric; say-on-pay 96%; board composition; strategic-holder nomination rights (Thoma Bravo/Holden Spaht, Borse Dubai, Investor AB).
5. Thoma Bravo SC 13D / 13D-A chain (2023-11-01 initial 14.84%; 2024-03-11 15.53%; 2024-07-30 7.42%; 2025-05-09 below 5%) and 424B7 secondary prospectuses (2024) — stake wind-down; concurrent NDAQ buyback of TB shares.
6. Form 4 corpus (166 filings, 2024–2026, EDGAR) — insider-transaction read: zero officer/director open-market purchases (code P); routine grant/vest/sell pattern.
7. 8-K earnings releases: Q4/FY2025 (2026-01-29) and Q1 2026 (2026-04-23) — net revenue, organic growth, ARR, ETP AUM, guidance, capital return.

Primary — Company materials

8. Nasdaq Q1 2026 earnings call transcript (2026-04-23) — via ROIC.ai. Management framing: “strongest start to a year in our history,” FinTech +18%/ARR +16%, index $79B TTM net inflows / $836B ETP AUM / avg AUM +32%, gross leverage 2.8×, $548M Q1 buyback, dividend to $0.31, Outcome-Related Options, tokenization, AI.
9. Nasdaq Investor Day (2026-03-01) materials and press — medium-term targets (CAP 6–10%, FinTech 10–14%, Solutions 9–12%); $3B buyback; +$0.04 dividend; $100M GenAI efficiency by end-2027.
10. Nasdaq Q1 2026 / Q4 2025 press releases (GlobeNewswire, 2026-04-23 / 2026-01-29).

Third-party quantitative (reconciled to filings)

11. ROIC.ai — income statement, balance sheet, cash flow, profitability ratios (ROE 19.9%, ROIC 9.5%), enterprise value (EV ~$55.6B at Q1 mark; ~$53.5B at current price), and valuation multiples (EV/EBITDA, EV/sales, P/E) FY2020–TTM.
12. AZI (azitrading.com) — valuation_index own-history percentiles (composite 55.8th, P/E 32.7th, P/B 54.5th, P/S 80.0th); 5-year adjusted price CSV (ATH $100.30 2026-01-16; 52-wk low $77.65 2026-06-25; close $78.56 2026-06-26; beta ~0.82); news feed.
13. Factorstoday — factor loadings (Momentum −0.44, Value −0.30, Growth −0.20, LowVol +0.26; market beta ~0.85–1.15); leaderboard (y1 −10.7%, lifetime maxDD −68.5%); related-stocks (MCO 0.97, SPGI 0.95, SSNC, RELX, ADP); specific vol 19.6%.

Secondary — industry, competitive, and recent-events context

14. CNBC (2026-06-02) — “The CFTC has sparked a potential revolution on Wall Street. Exchange stocks are dropping” — Kalshi BTC perps approval (May 31, 2026) and the exchange-group sell-off (CBOE −8%+, NDAQ ~−5%, CME −3.5%, ICE −2.5%).
15. Yahoo Finance / Stocktwits (2026-06-02) — TD Cowen and RBC notes on perps exposure; TD Cowen “limited downside to the Nasdaq” (least exposed).
16. TD Cowen (~2026-06-20–22) — NDAQ price-target cut to $98 (from $104), rating maintained.
17. Reuters / Business Standard (2026-04-30–05-01) — SEC accelerated approval of Nasdaq MRX Outcome-Related Options.
18. BusinessWire / CNBC (2026-05-18–19) — Polymarket private-company markets with Nasdaq Private Market as resolution-data provider.
19. CNBC (2026-06-26) — SpaceX Nasdaq-100 fast-track inclusion; Nasdaq IPO/listings leadership data.
20. Nasdaq IR / ainvest (2025) — listings leadership, $1.2T transfers (incl. Walmart), 2025 IPO proceeds.
21. SEC final rule 34-101070 (2024) and appellate decision (2025-10-14) — tick-size/access-fee rule; FINRA Notice (2025) — Section 31 fee to $0.00.
22. Mordor Intelligence / industry reports (2025) — AML/RegTech market sizing and competitive set (NICE Actimize, Feedzai, Featurespace/Visa, SAS, Oracle, FICO).
23. MSCI / S&P Global disclosures (2025) — index-licensing AUM scale and basis-point fee-compression context.